Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Gossamer Bio

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Where Gossamer Bio Stands With Analysts

Where Gossamer Bio Stands With Analysts

Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022

Recap: Gossamer Bio Q4 Earnings

Gossamer Bio (NASDAQ:GOSS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Gossamer Bio reported in-line EPS of $-0.74 versus an estimate of $-0.74.

Gossamer Bio Earnings Preview

Gossamer Bio (NASDAQ:GOSS) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate that Gossamer Bio will report an earnings per share (EPS) of $-0.74.

inkl

Read news from The Economist, FT, and more,
with one subscription

Organisations

Berkshire Hathaway

Delta Air Lines

Arista Networks

Western Digital

Micron Technology

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play